Increase of E-cigarette Use during Teenage Pregnancy

Industry Insight by 2FIRSTS.ai
Dec.15.2023
Increase of E-cigarette Use during Teenage Pregnancy
Teenage e-cigarette use during pregnancy has risen from 0.8% in 2016 to 4.1% in 2021, according to a study.

According to a study published online on December 13th in JAMA Network Open, the prevalence of e-cigarette use in late pregnancy among adolescents in the United States has increased from 0.8% in 2016 to 4.1% in 2021.

 

Researchers primarily analyzed data from the 2016-2021 Pregnancy Risk Assessment Monitoring System. They specifically focused on 10,428 teenagers aged 10-19 who had previously given birth to a singleton and provided information on their use of e-cigarettes or conventional cigarettes.

 

Although researchers found that the prevalence of exclusive e-cigarette use has increased by approximately five-fold, the percentage of pregnant women who only use conventional cigarettes has decreased from 9.2% in 2017 to 3.2% in 2021. The proportion of pregnant women who use both e-cigarettes and conventional cigarettes fluctuated between 0.6% and 1.6%.

 

There was no significant difference in the proportion of low birth weight among non-smoking or non-e-cigarette using adolescents (12.9%), e-cigarette only users (16.8%), or adolescents who used both cigarettes and e-cigarettes (17.6%). However, researchers found a significant association between smoking only and the proportion of low birth weight (24.6%).

 

In this study, Dr. Xiaozhong Wen, corresponding author from the Jacobs School of Medicine and Biomedical Sciences at the State University of New York, Buffalo, stated:

 

In our analysis, using only e-cigarettes and using both traditional cigarettes and e-cigarettes simultaneously appears to have no significant statistical association with lower birth weight. However, considering the lower prevalence of usage and limited sample size, this finding should be interpreted with caution.

 

The limitations of this study lie in the possibility that participants may underreport their use of e-cigarettes and traditional cigarettes out of concern for social stigma. Additionally, researchers lack information on the use of e-cigarettes during the first and second trimesters of pregnancy, exposure to secondhand smoke, marijuana use, and dietary habits.

 

This study was supported by the National Institute on Drug Abuse, the Center for Tobacco Products of the Food and Drug Administration, the National Heart, Lung, and Blood Institute, as well as the American Heart Association. One of the co-authors of the study has received grants from Pfizer Inc. and personal fees from Johnson & Johnson, the World Health Organization, and the Campaign for Tobacco-Free Kids.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada Studies UK-Style “Smoke-Free Generation” Tobacco Ban
Canada’s federal health minister, Majorie Michel, said she is looking into legislation that would permanently ban the sale of tobacco products to anyone born after 2008. She said Canada has seen the approach recently proposed in the United Kingdom and is reviewing it with partners. Health Canada previously said the Government of Canada has invested C$66 million annually since 2018 to help Canadians quit smoking and reduce the harms of nicotine addiction.
Apr.29 by 2FIRSTS.ai
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina Issues Resolution 549/2026 to Regulate Vapes, Heated Tobacco and Nicotine Pouches
Argentina’s government has created a comprehensive regulatory framework for nicotine products, including vapes, heated tobacco and nicotine pouches, through Resolution 549/2026 published in the Official Gazette. The new regulation ends the previous prohibitive framework and establishes rules to organize the market by requiring traceability, quality standards and mandatory registration for all manufacturers and retailers operating in the country.
May.06 by 2FIRSTS.ai
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08